financetom
Business
financetom
/
Business
/
23andMe Unit Offers Petros Pharmaceuticals' Impotency Medication
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
23andMe Unit Offers Petros Pharmaceuticals' Impotency Medication
May 14, 2024 9:32 AM

12:08 PM EDT, 05/14/2024 (MT Newswires) -- 23andMe Holding ( ME ) unit Lemonaid Health now offers Petros Pharmaceuticals' ( PTPI ) prescription erectile dysfunction drug Stendra through its telehealth platform, the company said Tuesday.

23andMe shares jumped 14% and Petros shares rose 1% in recent trading.

Price: 0.60, Change: +0.07, Percent Change: +14.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
South Star Upsized Non-Brokered Private Placement
South Star Upsized Non-Brokered Private Placement
Nov 10, 2025
08:14 AM EST, 11/10/2025 (MT Newswires) -- South Star Battery Metals ( STSBF ) over the weekend announced that, due to significant market demand, the company increased the size of its previously announced non-brokered private placement of units from C$6,255,000 to up to C$6,672,000 (US$4,800,000). ...
Camtek Q3 Non-GAAP Earnings, Revenue Rise; Issues Q4 Revenue Guidance
Camtek Q3 Non-GAAP Earnings, Revenue Rise; Issues Q4 Revenue Guidance
Nov 10, 2025
08:15 AM EST, 11/10/2025 (MT Newswires) -- Camtek ( CAMT ) reported Q3 non-GAAP net income Monday of $0.82 per diluted share, up from $0.75 a year earlier. Analysts polled by FactSet expected $0.80. Revenue for the quarter ended Sept. 30 was $126 million, up from $112.3 million a year earlier. Analysts surveyed by FactSet expected $125.1 million. For Q4,...
Osisko Development Q3 Loss Widens, Revenue Rises
Osisko Development Q3 Loss Widens, Revenue Rises
Nov 10, 2025
08:14 AM EST, 11/10/2025 (MT Newswires) -- Osisko Development ( ODV ) reported a Q3 net loss Monday of 0.80 Canadian dollar ($0.57) per diluted share, widening from a loss of CA$0.40 a year earlier. Revenue for the quarter ended Sept. 30 was CA$4.4 million, compared with CA$161,000 a year earlier. ...
Sonida Senior Living Announces Third Quarter 2025 Results
Sonida Senior Living Announces Third Quarter 2025 Results
Nov 10, 2025
DALLAS--(BUSINESS WIRE)-- Sonida Senior Living, Inc. ( SNDA ) (the “Company,” “Sonida,” “we,” “our,” or “us”) , a leading owner, operator and investor of senior housing communities, today announced its results for the third quarter ended September 30, 2025. “In the third quarter, total portfolio community NOI grew approximately 21%, driven by solid rent growth and strong results in the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved